Boston, MA, United States of America

Kevin P Dooley

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Kevin P Dooley: Innovator in Therapeutic Exosome Preparation

Introduction

Kevin P Dooley is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of therapeutic exosomes, holding a total of 4 patents. His work focuses on innovative methods for preparing exosomes that can be utilized in various therapeutic applications.

Latest Patents

One of Kevin's latest patents is centered around the preparation of therapeutic exosomes using membrane proteins. This invention relates to methods of preparing a therapeutic exosome by utilizing a protein that has been newly identified as being enriched on the surface of exosomes. The patent outlines methods for using these proteins for affinity purification of exosomes. Additionally, it provides techniques for localizing a therapeutic peptide on exosomes and targeting them to specific organs, tissues, or cells. The methods involve generating surface-engineered exosomes that incorporate one or more of the exosome proteins at a higher density, or a variant or fragment of the exosome protein.

Career Highlights

Throughout his career, Kevin has worked with notable companies, including Codiak Biosciences, Inc. His innovative approaches and research have positioned him as a key figure in the development of therapeutic exosome technologies.

Collaborations

Kevin has collaborated with esteemed colleagues such as Rane A Harrison and Russell E McConnell. Their combined expertise has contributed to advancements in the field of exosome research.

Conclusion

Kevin P Dooley is a distinguished inventor whose work in therapeutic exosome preparation has the potential to revolutionize medical treatments. His innovative patents and collaborations highlight his commitment to advancing science and technology in this vital area.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…